About this Fact Sheet
ProSciento’s NASH PASS® is a science-driven clinical research and patient registry platform, leveraging more than a decade of NASH therapeutic and operational expertise, and designed to overcome enrollment challenges inherent in NASH clinical trials. The platform streamlines and substantially improves site selection, patient access, and enrollment for NASH clinical trials. It is also an important, evolving tool to enhance the scientific knowledge of NAFLD and NASH disease progression and the development of novel biomarkers for clinical research.
